Reach Anti Plaque
NDC Package 66923-002-64
Package Information
Reach Anti Plaque is a . Marketed by Ranir Llc, this product is identified by NDC 66923-002 and is authorized under FDA application M022.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 66923 - Ranir Llc
- 66923-002 - Reach Anti Plaque
- 66923-002-64 - 400 mL in 1 BOTTLE
- 66923-002 - Reach Anti Plaque
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 66923-002-64 identifies a specific commercial package of 400 ml in 1 bottle of Reach Anti Plaque, labeled by Ranir Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ranir Llc on June 16, 2021. The current certification is valid through August 31, 2023.
How is this Ranir Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 66923000264. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.